JP2008500999A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500999A5
JP2008500999A5 JP2007513941A JP2007513941A JP2008500999A5 JP 2008500999 A5 JP2008500999 A5 JP 2008500999A5 JP 2007513941 A JP2007513941 A JP 2007513941A JP 2007513941 A JP2007513941 A JP 2007513941A JP 2008500999 A5 JP2008500999 A5 JP 2008500999A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylcarbonyl
compound
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007513941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500999A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/052418 external-priority patent/WO2005118541A2/en
Publication of JP2008500999A publication Critical patent/JP2008500999A/ja
Publication of JP2008500999A5 publication Critical patent/JP2008500999A5/ja
Pending legal-status Critical Current

Links

JP2007513941A 2004-05-28 2005-05-27 複素環式化合物およびアルドステロンシンターゼ阻害薬としてのそれらの使用 Pending JP2008500999A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH9162004 2004-05-28
CH11572004 2004-07-09
PCT/EP2005/052418 WO2005118541A2 (en) 2004-05-28 2005-05-27 Heterocyclic compounds and their use as aldosterone synthase inhibitors

Publications (2)

Publication Number Publication Date
JP2008500999A JP2008500999A (ja) 2008-01-17
JP2008500999A5 true JP2008500999A5 (cg-RX-API-DMAC7.html) 2008-07-10

Family

ID=34993240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007513941A Pending JP2008500999A (ja) 2004-05-28 2005-05-27 複素環式化合物およびアルドステロンシンターゼ阻害薬としてのそれらの使用

Country Status (11)

Country Link
US (1) US20080076794A1 (cg-RX-API-DMAC7.html)
EP (1) EP1748986B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008500999A (cg-RX-API-DMAC7.html)
AR (1) AR050251A1 (cg-RX-API-DMAC7.html)
AT (1) ATE490241T1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510412A (cg-RX-API-DMAC7.html)
CA (1) CA2568164A1 (cg-RX-API-DMAC7.html)
DE (1) DE602005025110D1 (cg-RX-API-DMAC7.html)
IL (1) IL179409A0 (cg-RX-API-DMAC7.html)
TW (1) TW200608978A (cg-RX-API-DMAC7.html)
WO (1) WO2005118541A2 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR049126A1 (es) * 2004-05-28 2006-06-28 Speedel Experimenta Ag Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
TW200716105A (en) * 2005-05-31 2007-05-01 Speedel Experimenta Ag Imidazole compounds
TW200804378A (en) * 2005-12-09 2008-01-16 Speedel Experimenta Ag Organic compounds
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
TW200808812A (en) * 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds
TW200808813A (en) * 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds
EP1886695A1 (en) * 2006-06-27 2008-02-13 Speedel Experimenta AG Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
CA2763565A1 (en) 2009-05-28 2010-12-02 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
PL2435409T3 (pl) 2009-05-28 2015-01-30 Novartis Ag Podstawione pochodne aminopropionowe jako inhibitory neprylizyny
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN103648495A (zh) 2011-07-08 2014-03-19 诺华股份有限公司 在高甘油三酯对象中治疗动脉粥样硬化的方法
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
SG11201506018PA (en) 2013-02-14 2015-08-28 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
EP3024845A1 (en) 2013-07-25 2016-06-01 Novartis AG Cyclic polypeptides for the treatment of heart failure
WO2015013169A2 (en) 2013-07-25 2015-01-29 Novartis Ag Bioconjugates of synthetic apelin polypeptides
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
WO2020110008A1 (en) 2018-11-27 2020-06-04 Novartis Ag Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorder
JP7657151B2 (ja) 2018-11-27 2025-04-04 ノバルティス アーゲー 代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン/ケキシン9型(pcsk9)阻害剤としての環状ペプチド
WO2023084449A1 (en) 2021-11-12 2023-05-19 Novartis Ag Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder
AR127698A1 (es) 2021-11-23 2024-02-21 Novartis Ag Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno
IL324432A (en) 2023-05-24 2026-01-01 Novartis Ag Naphthyridinone derivatives for the treatment of a disease or disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859691A (en) * 1987-07-08 1989-08-22 Ciba-Geigy Corporation Certain 1,2-benzisoxazole derivatives
GB8820730D0 (en) * 1988-09-02 1988-10-05 Erba Carlo Spa Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
DK0401707T3 (da) * 1989-06-05 1994-10-17 Daiichi Seiyaku Co Heterocyclisk forbindelse, et farmaceutisk lægemiddel og fremgangsmåde til fremstilling af disse
JP3170273B2 (ja) * 1989-06-05 2001-05-28 第一製薬株式会社 縮合トリアジン誘導体及びその中間体
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
WO1993015079A1 (en) * 1992-01-27 1993-08-05 Janssen Pharmaceutica N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
JPH0971586A (ja) * 1995-09-07 1997-03-18 Yamanouchi Pharmaceut Co Ltd 新規な二環性縮合イミダゾール誘導体
EP1311192A4 (en) * 1999-10-22 2006-03-01 Glaxo Group Ltd -G- (IN VIVO) IMAGING
US20030083342A1 (en) * 2002-08-27 2003-05-01 Steele Ronald Edward Combination of organic compounds

Similar Documents

Publication Publication Date Title
JP2008501000A5 (cg-RX-API-DMAC7.html)
JP2011525192A5 (cg-RX-API-DMAC7.html)
JP2019034943A5 (cg-RX-API-DMAC7.html)
JP2006524660A5 (cg-RX-API-DMAC7.html)
JP2008523082A5 (cg-RX-API-DMAC7.html)
JP2012510502A5 (cg-RX-API-DMAC7.html)
JP2019524883A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2018515555A5 (cg-RX-API-DMAC7.html)
JP2013544860A5 (cg-RX-API-DMAC7.html)
JP2005053931A5 (cg-RX-API-DMAC7.html)
JP2008510828A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2010501478A5 (cg-RX-API-DMAC7.html)
JP2012507535A5 (cg-RX-API-DMAC7.html)
JP2010155827A5 (cg-RX-API-DMAC7.html)
JP2009518365A5 (cg-RX-API-DMAC7.html)
JP2008546770A5 (cg-RX-API-DMAC7.html)
JP2013502441A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)
JP2013544854A5 (cg-RX-API-DMAC7.html)
JP2014519507A5 (cg-RX-API-DMAC7.html)
JP2011517697A5 (cg-RX-API-DMAC7.html)
JP2006501306A5 (cg-RX-API-DMAC7.html)
JP2010503690A5 (cg-RX-API-DMAC7.html)